πŸ‡ΊπŸ‡Έ FDA
Patent

US 10087172

Compounds and their methods of use

granted A61KA61K31/433A61P

Quick answer

US patent 10087172 (Compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/433, A61P, A61P35/00, A61P43/00